Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sapporo Clinical Laboratory was 3.20% per year. The lowest was -3.10% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Sapporo Clinical Laboratory (TSE:9776) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sapporo Clinical Laboratory Dividend Yield % Chart
Sapporo Clinical Laboratory Dividend Yield % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sapporo Clinical Laboratory's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sapporo Clinical Laboratory Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sapporo Clinical Laboratory's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sapporo Clinical Laboratory's Dividend Yield % falls into.
Sapporo Clinical Laboratory (TSE:9776) has a Dividend Yield % of 1.18% as of Jul. 20, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Sapporo Clinical Laboratory and its competitors. This is near median its historical median of 1.08. Over the past decade, Sapporo Clinical Laboratory's Dividend Yield % has ranged from 0.79 to 1.18.
Is Sapporo Clinical Laboratory's Dividend Yield % too high?
Sapporo Clinical Laboratory's current Dividend Yield % of 1.18% is near median its 10-year median of 1.08. Over the past 10 years, this metric has ranged from a low of 0.79 to a high of 1.18. The Healthcare Providers & Services industry median Dividend Yield % is 2.37. Sapporo Clinical Laboratory's value of 1.18% is 50.2% below this industry median. Overall, Sapporo Clinical Laboratory has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Sapporo Clinical Laboratory's Dividend Yield % compare to competitors?
Sapporo Clinical Laboratory's Dividend Yield % of 1.18% can be compared against companies in the Healthcare Providers & Services industry. The industry median Dividend Yield % is 2.37. Sapporo Clinical Laboratory's value of 1.18% is 50.2% below this benchmark. Historically, Sapporo Clinical Laboratory's own Dividend Yield % has ranged from 0.79 to 1.18 over the past decade. While the company's 10-year median is 1.08 vs. the industry median of 2.37, Sapporo Clinical Laboratory has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.37, based on 279 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sapporo Clinical Laboratory's current Dividend Yield % of 1.18% is 50.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Sapporo Clinical Laboratory and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sapporo Clinical Laboratory's current Dividend Yield % is 1.18%, which is near median its own 10-year median of 1.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sapporo Clinical Laboratory stock overvalued right now?
Sapporo Clinical Laboratory (TSE:9776) has a current Dividend Yield % of 1.18%. The stock's GF Value™ is 円1,041.47, compared to a current price of 円1,960.00 — trading 88.2% above its estimated fair value. The current Dividend Yield % is 1.18%, which is near median its 10-year median of 1.08 and 50.2% below the Healthcare Providers & Services industry median of 2.37. Sapporo Clinical Laboratory's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Sapporo Clinical Laboratory (TSE:9776), the current Dividend Yield % is 1.18% as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sapporo Clinical Laboratory (TSE:9776) Overvalued in 2026?
Based on GuruFocus' analysis, Sapporo Clinical Laboratory stock appears to be overvalued.
The current stock price of 円1,960.00 is trading 88.2% above its estimated GF Value™ of 円1,041.47.
Key valuation signals for TSE:9776:
Dividend Yield %: 1.18% (near median its 10-year median of 1.08)
GF Value™: 円1,041.47 vs. price of 円1,960.00 (88.2% above fair value)
Industry Position: 50.2% below the Healthcare Providers & Services median
No single metric tells the full story. See the TSE:9776 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sapporo Clinical Laboratory Inc. is a Japan based company engaged in offering clinical testing services. Its portfolio of services covers clinical examination, pathological examination, dispensing pharmacy, food hygiene environmental test, and radiation management. It is also engaged in the development of an integrated system for clinical testing.
43GF Score
Get the complete analysis for TSE:9776
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9776 has been successfully added to your 
